Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Biomaterials are broadly used in the medical procedures such as in orthopedics. Orthopedic biomaterials derived from organic or synthetic materials that help in the restoration of the structural integrity of bones, which are damaged due to trauma or disease. Orthopedic biomaterials are incorporated into the human body as part of devices designed to perform certain biological functions by substituting or repairing various tissue, such as ligaments, cartilage, bones, tendons, and others. The application sectors of the product include joint replacement, spine implants, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation.

The Global Orthopedic Biomaterial Market is estimated to be valued at US$ 11,896.5 million in 2020 and is expected to exhibit a CAGR of 9.9% during the forecast period (2020-2027).

Figure 1.Global Orthopedic Biomaterial Market Share (%) in Terms of Value, By Material 2020

Orthopedic Biomaterial  | Coherent Market Insights

The rising incidence of musculoskeletal disorders and chronic skeletal disorders is expected to drive the market growth during the forecast period.

The Increasing incidence of musculoskeletal disorders and chronic skeletal disorders is expected to drive Global Orthopedic Biomaterial Market growth over the forecast period. For instance, as per World Health Organization (WHO) in February 2021, approximately 1.71 billion people have musculoskeletal conditions worldwide.

request-sample

Orthopedic Biomaterial Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 11,896.5 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 9.9% 2027 Value Projection: US$ 23,035.3 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Material Type: Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites
  • By Application: Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation
  • By End User: Hospitals, Orthopedic Clinics, Others
Companies covered:

B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG,  Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc., and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Koninklijke DSM N.V. (DSM Biomedical B.V.), Invibio Ltd., and DePuy Synthes

Growth Drivers:
  • Increasing prevalence of musculoskeletal diseases and disorders
  • Rising population of geriatric age group
  • Increasing use of nanoparticles in orthopedic bio implants
Restraints & Challenges:
  • High cost of orthopedic bio implants and surgeries
  • Variations in reimbursement scenario

Figure 2.Global Orthopedic Biomaterial Market Share (%), by End user, 2020

Orthopedic Biomaterial  | Coherent Market Insights

Increasing government initiatives to spread awareness about Orthopedic Biomaterials is expected to drive the market growth during the forecast period

Several government and non-government programs are carried out in order to spread awareness among people regarding orthopedic biomaterials, which is expected to drive the market growth during the forecast period.

For Instance, in 2019, Government of India selected biodegradable orthopedic implant prototype for commercialization, which is safe and cost effective. The National Research Development Corporation (NRDC) of India, a technology transfer organization under the Department of Scientific & Industrial Research, Ministry of Science & Technology is consider  novel method which build biodegradable implant that is made of magnesium and hydroxyapatite.

Global Orthopedic Biomaterial Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 114 million infected individuals worldwide as of March 1st 2021.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Moreover, from March 2020 to June 2020, the health system in the U.S. experienced a significant decline in surgical volumes compared to 2019. The pandemic had a major impact on the U.S., Japan, China, as well as many major European countries. Due to the increasing prevalence of COVID-19, key players operating in the Global Orthopedic Biomaterial Market are focusing on research and development of novel products to support and combat the effect of COVID-19. COVID-19 pandemic has impacted the global economy and in turn, the

Global Orthopedic Biomaterial Market: Restraint

The major factors that hinder the growth of the Global Orthopedic Biomaterial Market include variations in reimbursement scenario and high cost associated with implants, joint replacement/reconstruction, and orthobiologics.

Key Players

Major players operating in the Global Orthopedic Biomaterial Market are B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG, Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc., and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Koninklijke DSM N.V. (DSM Biomedical B.V.), Invibio Ltd., DePuy Synthes.

Orthopedic biomaterials are synthetic or organic materials of biologic composition. Orthopedic biomaterials are commonly used in orthopedics, surgical implants, prosthetics, and various medical tools and devices. These materials are used to internally fix the fracture. Biomaterial devices are designed for various number of orthopedic applications, which are termed as ‘Implants’. The orthopedic biomaterials market involve bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid visco supplementation, cartilage repair, and machined bone allografts. These materials are implanted or applied in or near the indicated bone to expedite healing, stimulate bone tissue augmentation, compensate in areas where bone tissue is depleted and restore structure to allow for repair. Various biomaterials used in orthopedic are metals or metal alloys, ceramics, tissue adhesives, polymers, carbon materials, and composites, etc. Metal is the most commonly used orthopedic material due to its properties, such as corrosion resistance, high strength, hardness, ductility, biocompatibility, and formability.

Market Dynamics

Rise in the population with musculoskeletal disorders & chronic skeletal disorders, and increasing geriatric population are some of the major factors responsible for the growth of Global Orthopedic Biomaterial Market. For instance, according to the report published by the United Nation (UN) in 2017, the global population of age 60 and above was around 962 million, and is expected to reach 2.1 billion by 2050. Among orthopedic operations, knee replacement therapy is mostly carried out in geriatrics population. Moreover, according to the Journal of Bone and Joint Surgery, by 2030 the demand for knee arthroplastics is estimated to grow by 674% during 2005 and 2030 reaching 3.48 million procedures. 

Key features of the study:

  • This report provides in-depth analysis of the Global Orthopedic Biomaterial Market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global Orthopedic Biomaterial Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG,  Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc., and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Koninklijke DSM N.V. (DSM Biomedical B.V.), Invibio Ltd. and DePuy Synthes
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Global Orthopedic Biomaterial Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Orthopedic Biomaterial Market.

Detailed Segmentation:

  • Global Orthopedic Biomaterial Market, By Material Type:
    • Glass-ceramic & Bioactive Glasses
    • Calcium Phosphate Cements
    • Polymer
    • Metals
    • Composites
  • Global Orthopedic Biomaterial Market, By Application:
    • Joint Replacement
    • Spine Implants
    • Orthobiologics
    • Viscosupplementation
    • Bio-resorbable Tissue Fixation
  • Global Orthopedic Biomaterial Market, By End user:
    • Hospitals
    • Orthopedic Clinics
    • Other
  • Global Orthopedic Biomaterial Market, By Region:
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • B.Braun Melsungen AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • CONMED Corporation
    • Evonik Industries AG
    • Medtronic Plc.
    • Smith & Nephew Plc.
    • Stryker Corp
    • Victrex Plc.
    • Zimmer Biomet Holdings Inc.
    • Globus Medical
    • Heraeus Holding GmbH
    • Exactech Inc.
    • Collagen Matrix Inc.
    • Koninklijke DSM N.V. (DSM Biomedical B.V.),
    • Invibio Ltd.
    • DePuy Synthes

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Material Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Material Launch and Approvals
    • Regulatory Scenario
    • PEST Analysis
    • PORTER’s  Analysis
    • Reimbursement Scenario
    • Epidemiology
    • Company Share Analysis
  4. Global Orthopedic Biomaterial Market– Impact of Coronavirus (COVID-19) Pandemic
    • Economic Impact
    • Research and Development
    • Government Measures to combat COVID-19
  5. Global Orthopedic Biomaterial Market, By Material Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Glass-ceramic & Bioactive Glasses
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Calcium Phosphate Cements
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      •  
    • Polymer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Metals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Composites
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Orthopedic Biomaterial Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Joint Replacement
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Spine Implants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Orthobiologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Viscosupplementation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bio-resorbable Tissue Fixation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Orthopedic Biomaterial Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Orthopedic Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Orthopedic Biomaterial Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Material Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Material Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Material Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Material Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Material Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Material Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Braun Melsungen AG
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • CONMED Corporation
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Evonik Industries AG
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Smith & Nephew Plc.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Stryker Corp
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Victrex Plc.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Globus Medical
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Heraeus Holding GmbH
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Exactech Inc.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Collagen Matrix Inc.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Koninklijke DSM N.V.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Invibio Ltd.
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DePuy Synthes.
        • Company Overview
        • Material Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 31 figures on "Global Orthopedic Biomaterial” - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The Global Orthopedic Biomaterial Market size is estimated to be valued at US$ 11,896.5 million in 2020 and is expected to exhibit a CAGR of 9.9% during the forecast period.
Factors such as the increasing incidence of musculoskeletal disorders and chronic skeletal disorders are expected to drive the market growth during the forecast period.
Joint replacement segment is expected to hold a major market share owing to increasing product approvals and launches during the forecast period.
The major factors hampering growth of the market include variations in reimbursement scenario and High cost of orthopedic bio implants and surgeries.
Major players operating in the market are B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG, Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc., and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Koninklijke DSM N.V. (DSM Biomedical B.V.), Invibio Ltd. and DePuy Synthes
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner